Indeed, we see that several of our deregulated Ψ-lncs have been described in other tumor types, such as TPT1-AS1 in cervical cancer, and HGC11 in both prostate cancer and hepatocellular carcinoma (Zhang et al., 2016; Xu et al., 2017; Jiang et al., 2018). This evidence concerns the gene TPT1 and prostate carcinoma.